Skip to main content

Advertisement

Log in

CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Background

The recent literature shows an increased incidence of obstructive sleep apnea (OSA) in patients with idiopathic pulmonary fibrosis (IPF). On the other hand, there are no published studies related to continuous positive airway pressure (CPAP) treatment in this patient group. Our aim was to assess the effect of CPAP on sleep and overall life quality parameters in IPF patients with OSA and to recognize and overcome possible difficulties in CPAP initiation and acceptance by these patients.

Methods

Twelve patients (ten males and two females, age 67.1 ± 7.2 years) with newly diagnosed IPF and moderate to severe OSA, confirmed by overnight attended polysomnography, were included. Therapy with CPAP was initiated after a formal in-lab CPAP titration study. The patients completed the Epworth Sleepiness Scale (ESS), the Pittsburgh Sleep Quality Index (PSQI), the Functional Outcomes in Sleep Questionnaire (FOSQ), the Fatigue Severity Scale (FSS), the SF-36 quality of life questionnaire, and the Beck Depression Inventory (BDI) at CPAP initiation and after 1, 3, and 6 months of effective CPAP therapy.

Results

A statistically significant improvement was observed in the FOSQ at 1, 3, and 6 months after CPAP initiation (baseline 12.9 ± 2.9 vs. 14.7 ± 2.6 vs. 15.8 ± 2.1 vs. 16.9 ± 1.9, respectively, p = 0.02). Improvement, although not statistically significant, was noted in ESS score (9.2 ± 5.6 vs. 7.6 ± 4.9 vs. 7.5 ± 5.3 vs. 7.7 ± 5.2, p = 0.84), PSQI (10.7 ± 4.4 vs. 10.1 ± 4.3 vs. 9.4 ± 4.7 vs. 8.6 ± 5.2, p = 0.66), FSS (39.5 ± 10.2 vs. 34.8 ± 8.5 vs. 33.6 ± 10.7 vs. 33.4 ± 10.9, p = 0.44), SF-36 (63.2 ± 13.9 vs. 68.9 ± 13.5 vs. 72.1 ± 12.9 vs. 74.4 ± 11.3, p = 0.27), and BDI (12.9 ± 5.5 vs. 10.7 ± 4.3 vs. 9.4 ± 4.8 vs. 9.6 ± 4.5, p = 0.40). Two patients had difficulty complying with CPAP for a variety of reasons (nocturnal cough, claustrophobia, insomnia) and stopped CPAP use after the first month, despite intense follow-up by the CPAP clinic staff. Heated humidification was added for all patients in order to improve the common complaint of disabling nocturnal cough.

Conclusion

Effective CPAP treatment in IPF patients with OSA results in a significant improvement in daily living activities based on the FOSQ, namely an OSA-specific follow-up instrument. Improvement was also noted in other questionnaires assessing quality of life, though not to a statistically significant degree, probably because of the multifactorial influences of IPF on physical and mental health. The probability of poor CPAP compliance was high and could only be eliminated with intense follow-up by the CPAP clinic staff.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824

    Article  PubMed  Google Scholar 

  2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee (2002). Am J Respir Crit Care Med 165:277–304

  3. Olson AL, Swigris JJ (2012) Idiopathic pulmonary fibrosis: diagnosis and epidemiology. Clin Chest Med 33:41–50

    Article  PubMed  Google Scholar 

  4. Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, du Bois RM (2011) Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 140:221–229

    Article  PubMed  Google Scholar 

  5. Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D (2010) How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 14:387–390

    Article  PubMed  Google Scholar 

  6. Ruhle KH (2010) Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al. Sleep Breath 14:289

    Article  PubMed  Google Scholar 

  7. Mermigkis C, Chapman J, Golish J, Mermigkis D, Budur K, Kopanakis A, Polychronopoulos V, Burgess R, Foldvary-Schaefer N (2007) Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis. Lung 185:173–178

    Article  PubMed  Google Scholar 

  8. Rasche K, Orth M (2009) Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol 60(Suppl 5):13–14

    PubMed  Google Scholar 

  9. Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA (2009) Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 136:772–778

    Article  PubMed  Google Scholar 

  10. Pitsiou G, Bagalas V, Boutou A, Stanopoulos I, Argyropoulou-Pataka P (2013) Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia? Sleep Breath. doi:10.1007/s11325-012-0716-0

  11. Mermigkis C, Stagaki E, Amfilochiou A, Polychronopoulos V, Korkonikitas P, Mermigkis D, Bregou M, Kouris N, Bouros D (2009) Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 18:10–15

    Article  PubMed  CAS  Google Scholar 

  12. Krishnan V, McCormack MC, Mathai SC, Agarwal S, Richardson B, Horton MR, Polito AJ, Collop NA, Danoff SK (2008) Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 134:693–698

    Article  PubMed  Google Scholar 

  13. De Vries J, Kessels BL, Drent M (2001) Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 17:954–961

    Article  PubMed  Google Scholar 

  14. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK (2005) Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60:588–594

    Article  PubMed  CAS  Google Scholar 

  15. Swigris JJ, Stewart AL, Gould MK, Wilson SR (2005) Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 3:61

    Article  PubMed  Google Scholar 

  16. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64:631–636

    PubMed  CAS  Google Scholar 

  17. Patil SP, Schneider H, Schwartz AR, Smith PL (2007) Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 132:325–337

    Article  PubMed  Google Scholar 

  18. Lederer DJ, Jelic S, Bhattacharya J, Basner RC (2012) Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis? Arch Pathol Lab Med 136:470

    Article  PubMed  Google Scholar 

  19. Aihara K, Oga T, Harada Y, Chihara Y, Handa T, Tanizawa K, Watanabe K, Tsuboi T, Hitomi T, Mishima M, Chin K (2011) Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med 105:939–945

    Article  PubMed  Google Scholar 

  20. Wang H, Tian JL, Feng SZ, Sun N, Chen BY, Zhang Y (2013) The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet. Sleep Breath. doi:10.1007/s11325-012-0784-1

  21. Mermigkis C, Mermigkis D, Varouchakis G, Schiza S (2012) CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas. Sleep Breath 16:1–3

    Article  PubMed  Google Scholar 

  22. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4:157–171

    PubMed  Google Scholar 

  23. Iber K, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, Westchester

    Google Scholar 

  24. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, Smith PL, Schwartz AR, Redline S, Pack AI, Dinges DF (1997) An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 20:835–843

    PubMed  CAS  Google Scholar 

  25. Reimer MA, Flemons WW (2003) Quality of life in sleep disorders. Sleep Med Rev 7:335–349

    Article  PubMed  Google Scholar 

  26. Gooneratne NS, Weaver TE, Cater JR, Pack FM, Arner HM, Greenberg AS, Pack AI (2003) Functional outcomes of excessive daytime sleepiness in older adults. J Am Geriatr Soc 51:642–649

    Article  PubMed  Google Scholar 

  27. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213

    Article  PubMed  CAS  Google Scholar 

  28. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F (2002) Test–retest reliability and validity of the Pittsburgh sleep quality index in primary insomnia. J Psychosom Res 53:737–740

    Article  PubMed  Google Scholar 

  29. Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh sleep quality index. J Psychosom Res 45:5–13

    Article  PubMed  CAS  Google Scholar 

  30. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545

    PubMed  CAS  Google Scholar 

  31. Hjollund N, Andersen J, Bech P (2007) Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 27:5–12

    Google Scholar 

  32. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123

    Article  PubMed  CAS  Google Scholar 

  33. Ware JE (1994) SF-36 physical and mental health summary scales: A user’s manual. New England Medical Center Hospital, Health Institute, Boston

    Google Scholar 

  34. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33(4 Suppl):264–279

    Google Scholar 

  35. Martinez TY, Pereira CA, dos Santos ML, Ciconelli RM, Guimarães SM, Martinez JA (2000) Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 117:1627–1632

    Article  PubMed  CAS  Google Scholar 

  36. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151–169

    PubMed  CAS  Google Scholar 

  37. Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77–100

    Article  Google Scholar 

  38. Richter P, Werner J, Heerlein A, Kraus A, Sauer H (1998) On the validity of the Beck depression inventory. A review. Psychopathology 31:160–168

    Article  PubMed  CAS  Google Scholar 

  39. American Thoracic Society. Standardization of spirometry, 1994 update (1995). Am J Respir Crit Care Med 152:1107-1136

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charalampos Mermigkis.

Additional information

Charalampos Mermigkis and Izolde Bouloukaki made equal contributions to this work.

ClinicalTrials.gov identifier: NCT01637831

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mermigkis, C., Bouloukaki, I., Antoniou, K.M. et al. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?. Sleep Breath 17, 1137–1143 (2013). https://doi.org/10.1007/s11325-013-0813-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-013-0813-8

Keywords

Navigation